Testing effectiveness (Phase 2)Study completedNCT03411161
What this trial is testing
S 81694 Plus Paclitaxel in Metastatic Breast Cancer
Who this might be right for
Metastatic Breast CancerMetastatic Triple Negative Breast Cancer
Institut de Recherches Internationales Servier 22